Prescribing Information DESCRIPTION Each gram of ALOQUIN contains 1 . 25 % ( 12 . 5 mg ) Iodoquinol and 1 % ( 10 mg ) Aloe Polysaccharides .
Other ingredients : Purified Water , Carbomer 980 , Magnesium Aluminum Silicate , PEG - 20 Methyl Glucose Ether , Aminomethyl Propanol 95 , Biopeptide , Propylene Glycol , Glycerine , SDA Alcohol 40 B , Benzyl Alcohol , Trolamine , FD & C Blue # 1 and D & C Yellow # 10 .
Iodoquinol Iodoquinol is an antifungal and antibacterial agent .
Chemically , Iodoquinol is [ 5 , 7 - diiodo - 8 - quinolinol ] with the molecular formula ( C9H5I2NO ) and is represented by the following structural formula : [ MULTIMEDIA ] Aloe Polysaccharide The Aloe Polysaccharide in ALOQUIN is a patented mixture of acetylated mannan aloe polysaccharide .
Each purified acetylated mannan polysaccharide of specific molecular weight range and average is composed of the same repeating subunits shown below ( where m is mannose , n is galactose and p is glucose monomers ) : [ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ] INDICATIONS AND USAGE Based on a review of a related drug by the National Research Council and subsequent FDA classification for that drug , the indications are as follows : " Possibly " Effective : Contact or atopic dermatitis ; impetiginized eczema ; nummular eczema ; endogenous chronic infectious dermatitis ; stasis dermatitis ; pyoderma ; nuchal eczema and chronic eczematoid otitis externa ; acne urticata ; localized or disseminated neurodermatitis ; lichen simplex chronicus ; anogenital pruritus ( vulvae , scroti , ani ) ; folliculitis ; bacterial dermatoses ; mycotic dermatoses such as tinea ( capitis , cruris , corporis , pedis ) ; monliasis ; intertrigo .
Final classification of the less - than - effective indications requires further investigation .
CONTRAINDICATIONS ALOQUIN is contraindicated in those patients with a history of hypersensitivity to any components of the preparation .
WARNINGS AND PRECAUTIONS For external use only .
Keep away from eyes .
If irritation develops , the use of ALOQUIN should be discontinued and appropriate therapy instituted .
Some discoloration of the skin , hair and fabrics may occur , but can be removed with normal cleansing and laundry .
Not intended for use on infants or under diapers or occlusive dressings .
Iodoquinol may be absorbed through the skin and interfere with thyroid function tests .
If such tests are contemplated , wait at least one month after discontinuance of therapy to perform these tests .
The ferric chloride test for phenylketonuria ( PKU ) can yield a false positive result if Iodoquinol is present in the diaper or urine .
Prolonged use may result in overgrowth of non - susceptible organisms requiring appropriate therapy .
Keep out of reach of children .
Carcinogenesis , Mutagenisis and Impairment of Fertility Long term animal studies have not been performed to evaluate the carcinogenic potential of the effect on fertility of Iodoquinol .
Mutagenicity studies have not been performed with Iodoquinol .
Pregnancy Category C Animal reproductive studies have not been conducted with ALOQUIN .
It is not known whether ALOQUIN can cause fetal harm when administered to pregnant women or can affect reproductive capacity .
ALOQUIN should be given to pregnant women only if clearly needed .
Nursing Mothers It is not known whether this drug is excreted in human milk .
Because many drugs are excreted in human milk , caution should be exercised when ALOQUIN is administered to a nursing woman .
Pediatric Use Safety and effectiveness in pediatric patients under the age of 12 have not been established .
ADVERSE REACTIONS Adverse reactions from topical use of ALOQUIN is expected to be low when used as directed , due to low concentration of Iodoquinol present in this topical gel .
To achieve the equivalent of a common daily oral dose of nearly 2 , 000 mg Iodoquinol , one will need to use more than 2 full tubes of 60 g ALOQUIN in a single application .
Adverse reactions from oral form of Iodoquinol ( nearly 2 , 000 mg daily ) have been reported : various forms of skin eruptions , hives , itching , nausea , vomiting , abdominal cramps , diarrhea , anusitis , fever , chills , headache , vertigo and enlargement of thyroid .
DOSAGE AND ADMINISTRATION Apply to affected areas 3 - 4 times daily or as directed by a physician .
Follow your physician ' s directions regarding length of treatment after symptoms resolve .
HOW SUPPLIED NDC # 68040 - 706 - 16 60 gram gel tube NDC # 68040 - 706 - 01 1 gram gel individual pack NDC # 68040 - 706 - 08 10 - count carton of 1 gram gel sample packs - not for resale Each 1 gram gel pack contains multiple doses depending on the surface area treated .
STORAGE Store at room temperature 15 ° - 30 ° C ( 59 ° - 86 ° F ) .
Keep tightly closed .
Rx ONLY www . aloquin . com Manufactured for : Primus Pharmaceuticals , Inc .
Scottsdale , AZ 85251 www . primusrx . com Manufactured by : Sonar Products , Inc .
Carlstadt , NJ 07072 U . S . Patents # 6 , 436 , 679 ; # 6 , 271 , 214 ; # 6 , 133 , 440 ; # 5 , 925 , 357 ; # 5 , 902 , 796 ; # 5 , 708 , 038 ; # 5 , 703 , 060 ; # 5 , 468 , 737 ; other patents pending .
© 2009 Primus Pharmaceuticals , Inc .
All rights reserved .
ISS . 0309 # 15905 PRINCIPAL DISPLAY PANEL - 60 g Carton NDC 68040 - 706 - 16 AloQuin ™ GEL 1 . 25 % iodoquinol • 1 % aloe polysaccharides Contains Moisturizers • For Dermatological Use Only Rx Only Biopeptide Aloe Complex ™ Deeper Penetration • Patented Formula Net Wt .
60 g [ MULTIMEDIA ] [ MULTIMEDIA ]
